Geriatric Communication Skills Training Program for Oncology Clinicians

Memorial Sloan Kettering Cancer Center (MSK)

Status

Completed

Conditions

GI Cancer

Bone Marrow Transplant

GU Cancer

Lymphoma

Treatments

Behavioral: UCLA Geriatrics Attitudes Scale

Behavioral: Self-Efficacy Assessment

Behavioral: Consumer Assessment of Health Care Providers and Systems Program (CAHPS)

Behavioral: The Consultation and Relational Empathy (CARE) questionnaire

Behavioral: Patient activation measure (PAM) scale

Behavioral: Course Evaluations

Study type

Interventional

Funder types

Other

Identifiers

NCT03530969

18-183

Details and patient eligibility

About

The purpose of this study is to learn more about the effects of a training program designed to help doctors communicate better with older patients and their caregivers.

Enrollment

88 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Clinician Eligibility

MSK medical oncology Health Care Professionals (HCP) - specifically identified as Attendings, fellows, or Advance Practice Professional (APP) - either a Nurse Practitioner (NP) or Physician Assistant (PA) from GI, GU Oncology, Lymphoma, Bone Marrow Transplant or Geriatrics Service (five services with a large number of geriatric patients)
Willingness to be audio-recorded as per self-report
Clinician has individual clinic consultations with patients in the target population: 65 years of age and over, English speaking, and patients who have had a new visit within the last 6 months.

Patient Eligibility

MSK patients 65 years of age and over as per EMR
English speaking as per EMR
Being seen by one of the consented HCPs as per the HCP and/or electronic medical record (EMR)
Willingness to be audio-recorded as per self-report
Patient had their first visit with the clinician within the last 6 months

Caregiver Eligibility

English speaking as per EMR
Accompanying an MSK patient being seen by one of the consented HCPs as per the HCP and/or EMR

Exclusion criteria

Trial design

Primary purpose

Other

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

88 participants in 3 patient groups

GI/GU/Lymphoma Oncologists

Experimental group

Description:

Doctors specializing in treating gastrointestinal cancer (cancer of the stomach, pancreas, colon, etc.), genitourinary cancer (cancer of the genitals and urinary tract), and lymphoma (cancer affecting the blood and lymph nodes)

Treatment: